Literature DB >> 28183474

Midterm Safety and Efficacy of ABSORB Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent: An Updated Meta-Analysis.

Francis J Ha, Nitesh Nerlekar, James D Cameron, Martin R Bennett, Ian T Meredith, Nick E J West, Adam J Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28183474     DOI： 10.1016/j.jcin.2016.11.054

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN： 1936-8798            Impact factor:   11.195


× No keyword cloud information.
  4 in total

1.  Adverse events with bioresorbable vascular scaffolds in routine percutaneous coronary interventions: "coup de théâtre" or unfinished play?

Authors:  Salvatore Cassese; Oliver Husser; Adnan Kastrati
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

Review 2.  Long-term outcome of bioresorbable vascular scaffolds for the treatment of coronary artery disease: a meta-analysis of RCTs.

Authors:  Alberto Polimeni; Remzi Anadol; Thomas Münzel; Ciro Indolfi; Salvatore De Rosa; Tommaso Gori
Journal:  BMC Cardiovasc Disord       Date:  2017-06-07       Impact factor: 2.298

Review 3.  Mid-term outcomes of the Absorb BVS versus second-generation DES: A systematic review and meta-analysis.

Authors:  Cordula M Felix; Victor J van den Berg; Sanne E Hoeks; Jiang Ming Fam; Mattie Lenzen; Eric Boersma; Peter C Smits; Patrick W Serruys; Yoshinobu Onuma; Robert Jan M van Geuns
Journal:  PLoS One       Date:  2018-05-09       Impact factor: 3.240

4.  Undiscovered pathology of transient scaffolding t1remains a driver of failures in clinical trials.

Authors:  Alexander N Kharlamov
Journal:  World J Cardiol       Date:  2018-10-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.